DE69025102T2 - 3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung - Google Patents

3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung

Info

Publication number
DE69025102T2
DE69025102T2 DE69025102T DE69025102T DE69025102T2 DE 69025102 T2 DE69025102 T2 DE 69025102T2 DE 69025102 T DE69025102 T DE 69025102T DE 69025102 T DE69025102 T DE 69025102T DE 69025102 T2 DE69025102 T2 DE 69025102T2
Authority
DE
Germany
Prior art keywords
olefins
heteroaryl
fluoro
aryl
pharmaceutical activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69025102T
Other languages
English (en)
Other versions
DE69025102D1 (de
Inventor
James R Mccarthy
Donald P Matthews
Charlotte L Barney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69025102D1 publication Critical patent/DE69025102D1/de
Publication of DE69025102T2 publication Critical patent/DE69025102T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69025102T 1989-07-25 1990-07-24 3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung Expired - Fee Related DE69025102T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/384,944 US4981868A (en) 1989-07-25 1989-07-25 Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins

Publications (2)

Publication Number Publication Date
DE69025102D1 DE69025102D1 (de) 1996-03-14
DE69025102T2 true DE69025102T2 (de) 1996-05-30

Family

ID=23519395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69025102T Expired - Fee Related DE69025102T2 (de) 1989-07-25 1990-07-24 3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung

Country Status (8)

Country Link
US (1) US4981868A (de)
EP (1) EP0410379B1 (de)
JP (1) JP3154298B2 (de)
AT (1) ATE133647T1 (de)
AU (1) AU624258B2 (de)
CA (1) CA2021547C (de)
DE (1) DE69025102T2 (de)
ES (1) ES2085301T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068465A (en) * 1989-07-25 1991-11-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutically active 3-aryl-2-fluoro-1-olefins
CN1285779C (zh) 2001-09-28 2006-11-22 纳幕尔杜邦公司 可拉伸非织造纤网及其制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116975A (en) * 1976-10-18 1978-09-26 Hoffmann-La Roche Inc. Polyene compounds
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
CA2021521A1 (en) * 1989-07-25 1991-01-26 James R. Mccarthy Process for the synthesis of 2-fluoro-1-olefins

Also Published As

Publication number Publication date
CA2021547A1 (en) 1991-01-26
AU624258B2 (en) 1992-06-04
CA2021547C (en) 2000-10-24
ATE133647T1 (de) 1996-02-15
EP0410379A3 (en) 1992-04-08
EP0410379B1 (de) 1996-01-31
US4981868A (en) 1991-01-01
EP0410379A2 (de) 1991-01-30
AU5974090A (en) 1991-02-14
JP3154298B2 (ja) 2001-04-09
JPH0358950A (ja) 1991-03-14
ES2085301T3 (es) 1996-06-01
DE69025102D1 (de) 1996-03-14

Similar Documents

Publication Publication Date Title
ES2081936T3 (es) Composiciones anfoteras y formas polimericas de alfa-hidroxiacidos, y su uso terapeutico.
NO891470L (no) Fremgangsmaate for fremstilling av nye substituerte azetidinoner.
DE252290T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
DK1167354T3 (da) Racemisk huperzin A
ATE103815T1 (de) Verwendung von thrombospondin zur beschleunigung der wundheilung.
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
DE69025102T2 (de) 3-Aryl- und 3-Heteroaryl-2-fluor-1-olefine mit pharmazeutischer Wirkung
DK0566567T3 (da) Antihypertensive benzopyranderivater
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ES2070148T3 (es) Derivado de la glicerina y utilizacion farmacologica del mismo.
DK0635010T3 (da) Nye kardioprotektive midler
NO911051D0 (no) Fremgangsmaate for fremstilling av nye ascorbinsyrederivater.
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
DE68906437T2 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
ATE131382T1 (de) Mittel zur topischen behandlung von verbrennungen
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
ATE319442T1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
RU93051189A (ru) Средство для лечения радикулита

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee